Literature DB >> 3558911

Action of topical minoxidil in the bald stump-tailed macaque.

H Uno, A Cappas, P Brigham.   

Abstract

The effect of topical minoxidil (5% and 2% solutions) on hair regrowth was studied in the frontal bald scalp of 18 adolescent and adult stump-tailed macaques (Macaca arctoides). Gross observation of the hairiness and folliculogram analysis of the skin biopsy specimens have shown that minoxidil induces the enlargement of vellus follicles to the size of middle to terminal follicles (regrowth of hair effect), minoxidil maintains the terminal follicles in the prebald scalp of periadolescent animals (prevention of baldness effect), enlarged follicles regress after minoxidil is withdrawn, and hair follicular growth is once again stimulated when treatment with minoxidil is reinstituted. Hair regrowth was more prominent in the early stage of baldness among younger macaques than in baldness of longer duration in older animals. An in vitro study of 3H thymidine uptake revealed that the hair follicles in minoxidil-treated macaque skin showed significant enhancement of deoxyribonucleic acid synthesis in the follicular and perifollicular cells but not in the epidermal keratinocytes. Furthermore, the uptake of 3H minoxidil and its conversion to minoxidil sulfate (the active metabolite producing vasodilation) was relatively higher in the hair follicles than in the epidermis and dermis. Serum concentration of minoxidil was fairly constant 2, 4, 6, 15, and 24 hours after a single application (averaging 15 ng/ml with 5% minoxidil). Minoxidil's essential action in hair follicular growth may be as a potent vasodilator. However, a direct action on the hair follicle cannot be ruled out considering uptake and conversion of the drug to minoxidil sulfate within the hair follicle itself.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558911     DOI: 10.1016/s0190-9622(87)70084-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.

Authors:  Jing Sun; Kathleen A Silva; Kevin J McElwee; Lloyd E King; John P Sundberg
Journal:  Exp Dermatol       Date:  2008-10       Impact factor: 3.960

Review 2.  Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.

Authors:  Raquel N Rozner; Azael Freites-Martinez; Jerry Shapiro; Eliza B Geer; Shari Goldfarb; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2018-11-22       Impact factor: 4.872

3.  An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.

Authors:  Georgios N Stamatas; Jeff Wu; Apostolos Pappas; Paradi Mirmirani; Thomas S McCormick; Kevin D Cooper; Mary Consolo; Jane Schastnaya; Ivan V Ozerov; Alexander Aliper; Alex Zhavoronkov
Journal:  Cell Cycle       Date:  2017-06-08       Impact factor: 4.534

4.  An appraisal of laboratory models of androgenetic alopecia: A systematic review.

Authors:  S Ntshingila; N P Khumalo; M Engel; A T Arowolo
Journal:  Skin Health Dis       Date:  2021-03-05

5.  Minoxidil Nanoparticles Targeting Hair Follicles Enhance Hair Growth in C57BL/6 Mice.

Authors:  Yoshihiro Oaku; Akinari Abe; Yohei Sasano; Fuka Sasaki; Chika Kubota; Naoki Yamamoto; Tohru Nagahama; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

6.  [Androgenetic alopecia].

Authors:  R Hoffman
Journal:  Hautarzt       Date:  2004-01       Impact factor: 0.751

7.  Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Donald Chan; Monica Fornier; Shanu Modi; Devika Gajria; Stephen Dusza; Shari Goldfarb; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

8.  Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.

Authors:  Yi-Fan Chen; Li-Hsien Chen; Yu-Min Yeh; Pei-Ying Wu; Yih-Fung Chen; Lian-Yun Chang; Jang-Yang Chang; Meng-Ru Shen
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

9.  Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Kushagra Jain; Naresh Kumar Yadav
Journal:  BMC Ophthalmol       Date:  2020-06-05       Impact factor: 2.209

10.  Minoxidil may suppress androgen receptor-related functions.

Authors:  Cheng-Lung Hsu; Jai-Shin Liu; An-Chi Lin; Chih-Hsun Yang; Wen-Hung Chung; Wen-Guey Wu
Journal:  Oncotarget       Date:  2014-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.